JP2008525453A5 - - Google Patents

Download PDF

Info

Publication number
JP2008525453A5
JP2008525453A5 JP2007548311A JP2007548311A JP2008525453A5 JP 2008525453 A5 JP2008525453 A5 JP 2008525453A5 JP 2007548311 A JP2007548311 A JP 2007548311A JP 2007548311 A JP2007548311 A JP 2007548311A JP 2008525453 A5 JP2008525453 A5 JP 2008525453A5
Authority
JP
Japan
Prior art keywords
mmol
mixture
diazepan
ylcarbamate
500mhz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007548311A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008525453A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/045384 external-priority patent/WO2006071548A2/en
Publication of JP2008525453A publication Critical patent/JP2008525453A/ja
Publication of JP2008525453A5 publication Critical patent/JP2008525453A5/ja
Pending legal-status Critical Current

Links

JP2007548311A 2004-12-27 2005-12-14 緑内障と、rhoキナーゼを媒介とした他の疾患および症状を治療するためのアミノピラジン・アナログ Pending JP2008525453A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63938904P 2004-12-27 2004-12-27
PCT/US2005/045384 WO2006071548A2 (en) 2004-12-27 2005-12-14 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases

Publications (2)

Publication Number Publication Date
JP2008525453A JP2008525453A (ja) 2008-07-17
JP2008525453A5 true JP2008525453A5 (cg-RX-API-DMAC7.html) 2009-02-12

Family

ID=36615388

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007548311A Pending JP2008525453A (ja) 2004-12-27 2005-12-14 緑内障と、rhoキナーゼを媒介とした他の疾患および症状を治療するためのアミノピラジン・アナログ

Country Status (16)

Country Link
US (2) US20080269249A2 (cg-RX-API-DMAC7.html)
EP (1) EP1830853B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008525453A (cg-RX-API-DMAC7.html)
KR (1) KR100994173B1 (cg-RX-API-DMAC7.html)
CN (1) CN101102773B (cg-RX-API-DMAC7.html)
AR (1) AR053110A1 (cg-RX-API-DMAC7.html)
AT (1) ATE519488T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005322338B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0519508A2 (cg-RX-API-DMAC7.html)
CA (1) CA2590261C (cg-RX-API-DMAC7.html)
ES (1) ES2368338T3 (cg-RX-API-DMAC7.html)
MX (1) MX2007007797A (cg-RX-API-DMAC7.html)
PL (1) PL383491A1 (cg-RX-API-DMAC7.html)
TW (1) TW200633709A (cg-RX-API-DMAC7.html)
WO (1) WO2006071548A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200704959B (cg-RX-API-DMAC7.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008545660A (ja) * 2005-05-20 2008-12-18 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼ阻害剤として有用なピロロピリジン化合物
MX2008008328A (es) * 2005-12-22 2008-09-15 Alcon Res Ltd (indazol-5-il)-pirazinas y (1,3-dihidro-indol-2-ona)-pirazinas para tratar enfermedades y condiciones mediadas con rho cinasa.
WO2007126964A2 (en) * 2006-03-31 2007-11-08 Schering Corporation Kinase inhibitors
BRPI0713187A2 (pt) * 2006-07-20 2012-10-16 Mehmet Kahraman método de inibir rho-quinase, método de tratamento de doença mediada por rho-quinase, composto e composição farmacêutica
BRPI0717320A2 (pt) 2006-10-23 2013-10-22 Sgx Pharmaceuticals Inc Triazóis bicíclicos como moduladores de proteína cinase
WO2008070599A1 (en) * 2006-12-05 2008-06-12 Chung-Ming Sun Indazole compounds
US8648069B2 (en) 2007-06-08 2014-02-11 Abbvie Inc. 5-substituted indazoles as kinase inhibitors
CN101790526A (zh) * 2007-06-08 2010-07-28 雅培制药有限公司 用作激酶抑制剂的5-杂芳基取代的吲唑化合物
KR101712576B1 (ko) 2008-11-10 2017-03-06 버텍스 파마슈티칼스 인코포레이티드 Atr 키나제의 억제제로서 유용한 화합물
PL3354650T3 (pl) 2008-12-19 2022-06-13 Vertex Pharmaceuticals Incorporated Związki przydatne jako inhibitory kinazy atr
AU2010313392B2 (en) * 2009-10-30 2015-07-09 Janssen Pharmaceutica Nv Pyrazines as delta opioid receptor modulators
BR112012010253A8 (pt) 2009-10-30 2016-10-04 Janssen Pharmaceutica Nv compostos de pirimidina como moduladores do receptor delta opioide
BR112012010220A2 (pt) * 2009-10-30 2021-02-23 Janssen Pharmaceutical N.V. piridinas fenóxi-substituídas como modulares do receptor opioide
JP2013526538A (ja) 2010-05-12 2013-06-24 バーテックス ファーマシューティカルズ インコーポレイテッド Atrキナーゼ阻害剤として有用な化合物
JP2013526540A (ja) 2010-05-12 2013-06-24 バーテックス ファーマシューティカルズ インコーポレイテッド Atrキナーゼ阻害剤として有用な化合物
JP5836367B2 (ja) 2010-05-12 2015-12-24 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated Atrキナーゼ阻害剤として有用な化合物
US9096584B2 (en) 2010-05-12 2015-08-04 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
WO2011143423A2 (en) 2010-05-12 2011-11-17 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
US8962631B2 (en) 2010-05-12 2015-02-24 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
JP2013529643A (ja) 2010-06-23 2013-07-22 バーテックス ファーマシューティカルズ インコーポレイテッド Atrキナーゼ阻害剤として有用なピロロピラジン誘導体
CA2832100A1 (en) 2011-04-05 2012-10-11 Vertex Pharmaceuticals Incorporated Aminopyrazine compounds useful as inhibitors of tra kinase
JP2014522818A (ja) 2011-06-22 2014-09-08 バーテックス ファーマシューティカルズ インコーポレイテッド Atrキナーゼ阻害剤として有用な化合物
WO2012178123A1 (en) 2011-06-22 2012-12-27 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
WO2012178125A1 (en) 2011-06-22 2012-12-27 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
AU2012315384B2 (en) 2011-09-30 2017-08-10 Vertex Pharmaceuticals Incorporated Treating pancreatic cancer and non-small cell lung cancer with ATR inhibitors
IN2014KN00943A (cg-RX-API-DMAC7.html) 2011-09-30 2015-08-21 Vertex Pharma
US8853217B2 (en) 2011-09-30 2014-10-07 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
US8765751B2 (en) 2011-09-30 2014-07-01 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
RU2018147217A (ru) 2011-09-30 2019-01-18 Вертекс Фармасьютикалз Инкорпорейтед Способы получения соединений, которые можно использовать в качестве ингибиторов киназы atr
EP2776421A1 (en) 2011-11-09 2014-09-17 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
EP2776429A1 (en) 2011-11-09 2014-09-17 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
US8841449B2 (en) 2011-11-09 2014-09-23 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
US8841450B2 (en) 2011-11-09 2014-09-23 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
WO2013071090A1 (en) 2011-11-09 2013-05-16 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
CN104582795B (zh) 2012-04-05 2018-04-20 沃泰克斯药物股份有限公司 可用作atr激酶抑制剂的化合物及其组合疗法
DK2904406T3 (en) 2012-10-04 2018-06-18 Vertex Pharma METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE
US8912198B2 (en) 2012-10-16 2014-12-16 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
LT3418281T (lt) 2012-12-07 2021-01-11 Vertex Pharmaceuticals Inc. Pirazolo[1,5-a]pirimidinai, naudotini kaip atr kinazės inhibitoriai, skirti vėžinių ligų gydymui
WO2014143240A1 (en) 2013-03-15 2014-09-18 Vertex Pharmaceuticals Incorporated Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
KR101504722B1 (ko) 2013-06-12 2015-03-24 한국화학연구원 카모로놀 화합물을 유효성분으로 포함하는 심혈관 질환의 예방 및 치료용 약학적 조성물
HUE046727T2 (hu) 2013-12-06 2020-03-30 Vertex Pharma Az ATR-kináz inhibitoraként használható vegyület, 2-amino-6-fluoro-N-[5-fluoro-piridin-3-IL]-pirazolo-[1,5-A]-pirimidin-3-karboxamid, ennek elõállítása, különbözõ szilárd formái és ezek radioaktív nyomjelzett származékai
ES2777608T3 (es) 2014-06-05 2020-08-05 Vertex Pharma Derivados radiomarcados de un compuesto de 2-amino-6-fluoro-N-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útiles como inhibidores de ATR cinasa, la preparación de dicho compuesto y diferentes formas sólidas del mismo
US11179394B2 (en) 2014-06-17 2021-11-23 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of Chk1 and ATR inhibitors
US11464774B2 (en) 2015-09-30 2022-10-11 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
GB201715410D0 (en) 2017-09-22 2017-11-08 Syngenta Participations Ag Improvements in or relating to organic compounds
WO2019119207A1 (en) * 2017-12-18 2019-06-27 Merck Sharp & Dohme Corp. Purine inhibitors of human phosphatidylinositol 3-kinase delta
CN112142716B (zh) * 2020-10-29 2021-08-31 山东新时代药业有限公司 一种5元杂芳基取代的吡嗪衍生物及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3719609B2 (ja) * 1995-12-21 2005-11-24 アルコン ラボラトリーズ,インコーポレイテッド 緑内障および眼虚血の治療のための特定のイソキノリンスルホニル化合物の使用
US6586425B2 (en) * 1996-02-21 2003-07-01 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
US5798380A (en) * 1996-02-21 1998-08-25 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
PT956865E (pt) * 1996-08-12 2007-07-30 Mitsubishi Pharma Corp Medicamentos compreendendo inibidores da rho cinase.
KR100616466B1 (ko) * 1998-08-17 2006-08-29 센주 세이야꾸 가부시키가이샤 녹내장 예방/치료제
AU4144400A (en) * 1999-04-27 2000-11-10 Mitsubishi Pharma Corporation Preventives/remedies for liver diseases
US6348494B1 (en) * 2000-11-21 2002-02-19 American Home Products Corporation Ethers of o-desmethyl venlafaxine
ES2266171T3 (es) * 2000-03-16 2007-03-01 Mitsubishi Pharma Corporation Compuestos de amida y su uso.
JP4776138B2 (ja) * 2000-03-31 2011-09-21 田辺三菱製薬株式会社 腎臓疾患予防・治療剤
EP1403255A4 (en) * 2001-06-12 2005-04-06 Sumitomo Pharma RHO KINASE INHIBITORS
DE60234269D1 (de) 2001-11-21 2009-12-17 Pharmacia & Upjohn Co Llc Substituierte aryl 1,4-pyrazin derivate
AU2002358390A1 (en) * 2001-12-18 2003-06-30 Astrazeneca Ab Novel compounds
US7094789B2 (en) * 2002-07-22 2006-08-22 Asahi Kasei Pharma Corporation 5-substituted isoquinoline derivatives
CA2496197A1 (en) * 2002-08-20 2004-03-04 Neurogen Corporation 5-substituted-2-arylpyrazines as modulators of crf receptors
GB0219746D0 (en) * 2002-08-23 2002-10-02 Inst Of Ex Botany Ascr Azapurine derivatives
WO2004084824A2 (en) * 2003-03-24 2004-10-07 Merck & Co., Inc. Biaryl substituted 6-membered heterocyles as sodium channel blockers
GB2400101A (en) * 2003-03-28 2004-10-06 Biofocus Discovery Ltd Compounds capable of binding to the active site of protein kinases
CA2543644A1 (en) * 2003-10-27 2005-05-06 Astellas Pharma Inc. Pyrazine derivatives and pharmaceutical use thereof
WO2005058876A1 (en) * 2003-12-16 2005-06-30 Gpc Biotech Ag Pyrazine derivatives as effective compounds against infectious diseases
EP1737841A1 (en) * 2004-04-01 2007-01-03 Astellas Pharma Inc. Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists

Similar Documents

Publication Publication Date Title
ES2428503T3 (es) 1,4-Diaril-dihidropirimidin-2-onas y su uso como inhibidores de elastasa de neutrófilos humanos
EP4549440A1 (en) Class of prmt5 inhibitors and use thereof
JP3346437B2 (ja) 複素環化合物
JP4859672B2 (ja) 5−ht4受容体作動活性を有する1−イソプロピル−2−オキソ−1,2−ジヒドロピリジン−3−カルボキサミド誘導体
ES2975436T3 (es) Enantiómeros (R) y (S) de n-(5-(3-hidroxipirrolidin-1-il)-2-morfolinooxazolo[4,5-b]piridin-6-il)-2-(2-metilpiridin-4- il)oxazol-carboxamida como inhibidores de IRAK4 para el tratamiento del cáncer
ES2385118T3 (es) Derivados de quinazolina sustituida con sulfoximina como inmunomoduladores, su preparación y uso como medicamentos
JP2012519196A5 (cg-RX-API-DMAC7.html)
CN103724329B (zh) 4-[5-(吡啶-4-基)-1h-[1,2,4]三唑-3-基]吡啶-2-甲腈的制备方法
TW200536545A (en) Pyrazine derivatives and pharmaceutical use thereof
ATE419252T1 (de) Antagonisten des a2b-adenosinrezeptors
EA035168B1 (ru) Полициклические соединения в качестве ингибиторов тирозинкиназы брутона
JP6204223B2 (ja) チオピラノース化合物等の製造方法
CN103724258B (zh) 一种索拉非尼的制备方法
CN119768400A (zh) 一种稠环化合物、其用途及含其的药物组合物
CN102321073A (zh) 一种尼罗替尼的制备方法
IE55839B1 (en) Azetidine compounds
WO1996004251A1 (en) Heterocyclic compound
CN103497146B (zh) 2-(n-芳甲基哌啶-4-氨基)-4-(取代苯酚)苯环衍生物及其制备方法与应用
CN114026069B (zh) 制造(s)-3-羟基-1-(1h-吲哚-5-基)-2-氧代-吡咯烷-3-甲酸3,5-二氟-苄基酰胺的工艺
CN120302970A (zh) 制备抗体药物缀合物的方法
CN102924548A (zh) 卡培他滨的合成方法
CN103087132B (zh) β-核苷的合成
CHEN et al. Synthesis and Anti-tumor Evaluation of Nitrile-Containing Gambogic Acid Derivatives
CN104910068A (zh) 一种2-氰基异烟酸酰肼1.5对甲苯磺酸盐的合成方法
CN102516146B (zh) 5位为氮的四元氮杂螺环衍生物及其制备方法和用途